Seraphic Pharma Formulations Private Limited
About Seraphic Pharma Formulations Private Limited
Data last updated:
Seraphic Pharma Formulations Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U74999RJ2017PTC057181. Its GSTIN is 08AAYCS1185M1ZF (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Amit Kumar Ganeriwal and Pragati Ganeriwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 84 Tulip Enclave Vidhyadhar Nagar, Jaipur, Rajasthan, India – 302039.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Seraphic Pharma Formulations Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressG – 84 Tulip Enclave Vidhyadhar Nagar, Jaipur, Rajasthan, India – 302039
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Seraphic Pharma Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Seraphic Pharma Formulations Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Seraphic Pharma Formulations Private Limited, buy the company report.
Board of directors of Seraphic Pharma Formulations Private Limited
Seraphic Pharma Formulations has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Kumar Ganeriwal Also directs: Anjanisuth Residency LLP | Director | 13 Feb 2017 | 9 Years 8 Months | Current |
| Pragati Ganeriwal | Director | 13 Feb 2017 | 9 Years 8 Months | Current |
| Dinesh Kumar Biyani Also directs: Finegrow Industries Private Limited, DKB Infra & Realty Developers Private Limited, Bhaskar Realhomecon Private Limited and 1 more | Director | 13 Feb 2017 | 9 Years 8 Months | Current |
| Savita Bansal | Director | 01 Apr 2017 | 9 Years 7 Months | Current |
Auditor
Seraphic Pharma Formulations Private Limited is audited by Agarwal Goyal & Jalan for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Agarwal Goyal & Jalan | FY 2023 | 0016160C |
Shareholding
The shareholding of Seraphic Pharma Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Seraphic Pharma Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Seraphic Pharma Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Seraphic Pharma Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Seraphic Pharma Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAYCS1185M1ZF | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Seraphic Pharma Formulations Private Limited, buy the company report.
Recent activity
Seraphic Pharma Formulations Private Limited has 6 board changes on record since 2017: 4 appointments and 2 cessations. The latest: Savita Bansal ceased to be Additional Director on 30 Sep 2017.
Frequently asked questions
Seraphic Pharma Formulations is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 February 2017 (9+ years old) and is registered under CIN U74999RJ2017PTC057181.
Seraphic Pharma Formulations has 4 current directors:
- Amit Kumar Ganeriwal - Director
- Pragati Ganeriwal - Director
- Dinesh Kumar Biyani - Director
- Savita Bansal - Director
The latest financial statements of Seraphic Pharma Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Seraphic Pharma Formulations is 08AAYCS1185M1ZF, registered in Rajasthan.
The CIN (Corporate Identification Number) of Seraphic Pharma Formulations is U74999RJ2017PTC057181. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Seraphic Pharma Formulations was incorporated on 13 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Jaipur.
Savita Bansal ceased to be Additional Director on 30 Sep 2017. Savita Bansal was appointed as Director on 01 Apr 2017. Manoj Kumar Sharma ceased to be Director on 23 Feb 2017. Seraphic Pharma Formulations has 6 board changes on record in total.
The registered office of Seraphic Pharma Formulations is at G – 84 Tulip Enclave Vidhyadhar Nagar, Jaipur, Rajasthan, India – 302039.
Seraphic Pharma Formulations operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Seraphic Pharma Formulations is compliant as of 24 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
